Published in Folia Haematol Int Mag Klin Morphol Blutforsch on January 01, 1985
Improved survival in liver transplant recipients receiving prolonged-release tacrolimus in the European Liver Transplant Registry. Am J Transplant (2015) 1.46
Liver transplantation in Eastern Europe. Liver Transpl (2000) 1.39
Review and prospects of magnonic crystals and devices with reprogrammable band structure. J Phys Condens Matter (2014) 1.36
Magnonic band engineering by intrinsic and extrinsic mirror symmetry breaking in antidot spin-wave waveguides. Sci Rep (2013) 1.20
Two autologous transplants in the treatment of patients with Hodgkin's lymphoma: analysis of prognostic factors and comparison with a single procedure. Leuk Lymphoma (2007) 1.11
Evidence against the exon theory of genes derived from the triose-phosphate isomerase gene. Proc Natl Acad Sci U S A (1995) 1.06
A human putative Suv3-like RNA helicase is conserved between Rhodobacter and all eukaryotes. Acta Biochim Pol (1999) 1.01
Implications of overweight in gastric cancer: A multicenter study in a Western patient population. Eur J Surg Oncol (2010) 1.00
Diagnosis and treatment of sigmoidal endometriosis--a case report. Med Sci Monit (2001) 0.98
Forbidden band gaps in the spin-wave spectrum of a two-dimensional bicomponent magnonic crystal. Phys Rev Lett (2012) 0.96
Adjuvant chemotherapy with etoposide, adriamycin and cisplatin compared with surgery alone in the treatment of gastric cancer: a phase III randomized, multicenter, clinical trial. Oncology (2010) 0.96
Imatinib therapy prior to myeloablative allogeneic stem cell transplantation. Bone Marrow Transplant (2005) 0.95
The haploinsufficient Col3a1 mouse as a model for vascular Ehlers-Danlos syndrome. Vet Pathol (2010) 0.94
Erratic evolution of glycerol-3-phosphate dehydrogenase in Drosophila, Chymomyza, and Ceratitis. J Mol Evol (1997) 0.92
Outcome of four high-risk pregnancies in female liver transplant recipients on tacrolimus immunosuppression. Transplant Proc (2006) 0.89
Treatment of early hepatic artery thrombosis after liver transplantation. Transplant Proc (2011) 0.88
Heterozygosity for the alpha1-antitrypsin Z allele may confer genetic risk of cholangiocarcinoma. Aliment Pharmacol Ther (2010) 0.88
Choice of transplantation techniques and indications for liver transplantation in polycystic liver disease in patients with no signs of end-stage liver disease. Transplant Proc (2008) 0.87
Gallstone disease in Swedish twins: risk is associated with ABCG8 D19H genotype. J Intern Med (2010) 0.87
2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland. Eur J Haematol (1999) 0.86
Correlation between selected prognostic factors and postoperative course in liver transplant recipients. Transplant Proc (2009) 0.84
Orthotopic liver transplantation for cholestatic diseases. Hepatogastroenterology (2010) 0.84
Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG). Ann Hematol (2006) 0.84
Vascular complications related to liver transplantation. Transplant Proc (2000) 0.84
Rehabilitation and 6-minute walk test after liver transplantation. Transplant Proc (2011) 0.84
Pathomorphological features of acute rejection in patients after orthotopic liver transplantation: own experience. Transplant Proc (2006) 0.83
Two-stage transjugular intrahepatic porta-systemic shunt for patients with cirrhosis and a high risk of portal-systemic encephalopathy patients as a bridge to orthotopic liver transplantation: a preliminary report. Transplant Proc (2006) 0.83
Patient with liver epithelioid hemangioendothelioma treated by transplantation: 3 years' observation. Transplant Proc (2006) 0.83
TIPS: a therapy to prevent variceal rebleeding in patients listed for liver transplantation. Transplant Proc (2002) 0.83
Recurrence of primary sclerosing cholangitis in patients after liver transplantation. Transplant Proc (2006) 0.83
Acute lymphoblastic leukemia in elderly: the Polish Adult Leukemia Group (PALG) experience. Ann Hematol (2003) 0.83
Microvesicular liver graft steatosis as a risk factor of initial poor function in relation to suboptimal donor parameters. Transplant Proc (2009) 0.83
Biliary tract complications following liver transplantation. Transplant Proc (2003) 0.82
Safety and efficacy of steroid-free immunosuppression with tacrolimus and daclizumab in liver transplant recipients: 6-year follow-up in a single center. Transplant Proc (2009) 0.82
Results of treatment of acute liver failure patients with use of the prometheus FPSA system. Transplant Proc (2009) 0.81
The use Prometheus FPSA system in the treatment of acute liver failure: preliminary results. Transplant Proc (2006) 0.81
Low-dose hormonal contraception after liver transplantation. Transplant Proc (2007) 0.81
Assessment of early biliary complications after orthotopic liver transplantation and their relationship to the technique of biliary reconstruction. Transplant Proc (2006) 0.81
Renal function after liver transplantation: calcineurin inhibitor nephrotoxicity. Transplant Proc (2003) 0.80
Liver regeneration in 120 consecutive living-related liver donors. Transplant Proc (2009) 0.80
Pregnancy outcomes among female recipients after liver transplantation: further experience. Transplant Proc (2011) 0.80
Dysphagia and retrosternal pain related to a round plastic foreign body impacted in the esophageal wall for over 20 years. Endoscopy (2008) 0.80
Biliary complications in relation to the technique of biliary reconstruction in adult liver transplant recipients. Transplant Proc (2007) 0.80
Liver transplantation in patients with hepatic failure. Transplant Proc (2002) 0.79
Tremor associated with focal and segmental dystonia. Neurol Neurochir Pol (2013) 0.79
Vascular complications after liver transplantation. Transplant Proc (2003) 0.79
Resection of the liver in a metastatic disease caused by renal carcinoma. Mater Med Pol (1995) 0.79
High-resolution 1H nuclear magnetic resonance spectroscopy analysis of bile samples obtained from a patient after orthotopic liver transplantation: new perspectives. Transplant Proc (2003) 0.79
Efficacy of antibiotic penetration into pancreatic necrosis. HPB (Oxford) (2006) 0.79
Doxorubicin- and daunorubicin-glutathione conjugates, but not unconjugated drugs, competitively inhibit leukotriene C4 transport mediated by MRP/GS-X pump. Biochem Biophys Res Commun (1998) 0.79
Early results of orthotopic liver transplantations using the technique of inferior vena cava anastomosis. Transplant Proc (2006) 0.78
The clinical characteristics and the role of surgery and imatinib treatment in patients with liver metastases from c-Kit positive gastrointestinal stromal tumors (GIST). Neoplasma (2003) 0.78
Evaluation of total tumor volume and pretransplantation α-fetoprotein level as selection criteria for liver transplantation in patients with hepatocellular cancer. Transplant Proc (2013) 0.78
2-chlorodeoxyadenosine (2-CdA) in 2-hour versus 24-hour intravenous infusion in the treatment of patients with hairy cell leukemia. Leuk Lymphoma (1996) 0.78
Orthotopic liver transplantation for fulminant hepatic failure. Transplant Proc (2006) 0.78
Preoperative concurrent chemotherapy and radiotherapy for local-regional and advanced squamous cell carcinoma of the thoracic oesophagus: preliminary results of a pilot study. Eur J Surg Oncol (1991) 0.78
Analysis of drug transport kinetics in multidrug-resistant cells: implications for drug action. Curr Med Chem (2001) 0.78
Tremor in neurodegenerative ataxias, Huntington disease and tic disorder. Neurol Neurochir Pol (2013) 0.77
Prediction of graft loss and death in patients with primary sclerosing cholangitis. Transplant Proc (2009) 0.77
The expression of CD 15 antigen on myeloid leukaemia cells--a new prognostic index for complete remission and for survival. Folia Haematol Int Mag Klin Morphol Blutforsch (1989) 0.77
Menstrual function in female liver transplant recipients of reproductive age. Transplant Proc (2009) 0.77
New concepts in organ transplantation. Transplant Proc (2004) 0.77
Anatomical alteration of the vascular tree observed during living related liver transplantation. Transplant Proc (2003) 0.77
Comparison of the results of liver transplantation for elective versus urgent indications. Transplant Proc (2003) 0.77
CD-15 antigen detected by the VIM-D5 monoclonal antibody for prediction of ability to achieve complete remission in acute nonlymphocytic leukemia. Acta Haematol (1986) 0.77
Immature hepatic tumor of bimodal differentiation in a young adult patient: a novel lesion expressing beta-catenin and mimicking a distinct phase of hepatogenesis. J Hepatol (2001) 0.77
Current treatments of primary sclerosing cholangitis. Curr Med Chem (2007) 0.77
Liver retransplantation: indications and results. Transplant Proc (2002) 0.77
Clinical significance of lymphocytes hepatocyte growth factor mRNA expression in patients after liver transplantation. Transplant Proc (2007) 0.77
Cytomegalovirus infection as a common complication following liver transplantation. Transplant Proc (2003) 0.77
Influence of selected factors on survival after liver retransplantation. Transplant Proc (2011) 0.77
Impact of tumor characteristic on the outcome of liver transplantation in patients with hepatocellular carcinoma. Transplant Proc (2009) 0.76
Acute liver transplant rejection: incidence and the role of high-doses steroids. Transplant Proc (2003) 0.76
Results of surgical treatment of cervical esophageal diverticula. Dis Esophagus (1998) 0.76
[Analysis of morbidity risk in patients after liver resection]. Wiad Lek (1997) 0.76
Liver transplantation: comparison of the classical orthotopic and piggyback techniques. Transplant Proc (2002) 0.76
Prevalence and predictors of acute renal injury in liver transplant recipients. Transplant Proc (2009) 0.76
Universal fresh-frozen plasma (Uniplas): an exploratory study in adult patients undergoing elective liver resection. Vox Sang (2005) 0.76
Comparison of modifications of the rosette test for detecting T lymphocytes. Arch Immunol Ther Exp (Warsz) (1976) 0.76
The relevance of intestinal dysbiosis in liver transplant candidates. Transpl Infect Dis (2015) 0.76
Hepatic artery reconstruction prior to orthotopic liver transplantation. Transplant Proc (2003) 0.75
Gas exchange abnormalities in patients listed for liver transplantation. J Physiol Pharmacol (2006) 0.75
Pregnancy and delivery after liver transplantation. Transplant Proc (2005) 0.75
Effect of immunosuppressive regimen on acute rejection and liver graft function. Transplant Proc (2003) 0.75
Acid phosphatase activity of the lymphocytes during polychemotherapy of lymphoproliferative diseases. Arch Immunol Ther Exp (Warsz) (1981) 0.75
[Usefulness of CA-125 antigen for monitoring neoplastic processes in patients with ovarian tumors]. Ginekol Pol (1994) 0.75
[Intestinal absorption of fats after exchange transposition of the jejunum and ileum in dogs]. Pol Tyg Lek (1982) 0.75
Lymphocyte as a myeloid cell precursor. Jpn J Exp Med (1969) 0.75
[Morphological changes in the small intestine mucosa of dogs after exchange transposition of the jejunum and ileum]. Pol Tyg Lek (1981) 0.75
[Effect of toxic factors on the incidence of hematopoietic system damage]. Pol Arch Med Wewn (1981) 0.75
[Intestinal absorption of D-xylose after transposition of the jejunum and ileum in the dog]. Pol Tyg Lek (1983) 0.75
[Reverse transcriptase and its hypothetical role in tumor etiology]. Postepy Hig Med Dosw (1974) 0.75
Permanent metabolic alkalosis in mice following splenectomy or thymectomy. Jpn J Exp Med (1974) 0.75
[Budd-Chiari syndrome]. Pol Tyg Lek (1981) 0.75
[Instrument-induced esophageal perforation]. Wiad Lek (1982) 0.75
[Incidence of pulmonary artery embolism]. Pol Tyg Lek (1969) 0.75
[Comparison of efficacy of various methods of thyroglobulin measurements in differentiated thyroid cancer]. Wiad Lek (2001) 0.75
[Usefulness of simple oral loading with a fat meal for the evaluation of intestinal absorption of lipids]. Wiad Lek (1981) 0.75
[Evaluation of bone density in women after thyroid cancer surgery and treatment with suppressive doses of L-thyroxine]. Wiad Lek (2001) 0.75